Search Results 801-810 of 16201 for vagus

  1. Publications

    Publications. Buchl SC, Kim HN, Hur B, Simon WL, Langley MR, Sung J, Scarisbrick IA. Delayed atorvastatin delivery promotes recovery after experimental ...

  2. Trigeminal neuralgia - Doctors and departments - Mayo Clinic

    Learn about this nerve condition that can jolt areas on the face with electric-shock-like pain.

  3. Non-invasive Treatment for Long COVID Brain Fog - Mayo Clinic

    This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome. Participation ...

  4. A Study Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome - Mayo Clinic

    All medications or interventions for epilepsy (including ketogenic diet [KD] and vagal nerve stimulation [VNS]) must be stable for at least 4 weeks prior to ...

  5. https://www.mayoclinic.org/patient_consumer_drug1.xml

  6. Men's health

    Do you know the biggest threats to men's health? Heart disease and cancer top the list. Others include injury, lung disease, stroke and diabetes.

  7. Neurology - Clinical trials

    and/or disease duration, and whether there is a left-right difference in the density of a-syn pathology. Specific Aim 2. Determine, with a second SMG biopsy in ...

  8. A Study to Evaluate Minimal Residual Disease in Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different anticoagulants. Participation ...

  9. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...

  10. A Study to Evaluate Gene Therapy to Treat Neovascular Age-related Macular Degeneration - Mayo Clinic

    The primary objective of this study is to evaluate mean change in best-corrected visual acuity (BCVA) of RGX-314 relative to ranibizumab at Week 38. Second ...